Global CAR-T Cellular Immunotherapy Drug Market Insights, Forecast to 2029
This report presents an overview of global market for CAR-T Cellular Immunotherapy Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of CAR-T Cellular Immunotherapy Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CAR-T Cellular Immunotherapy Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CAR-T Cellular Immunotherapy Drug revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global CAR-T Cellular Immunotherapy Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for CAR-T Cellular Immunotherapy Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, Kite Pharma, Bristol Myers Squibb and Fosun Pharma, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CAR-T Cellular Immunotherapy Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR-T Cellular Immunotherapy Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of CAR-T Cellular Immunotherapy Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for CAR-T Cellular Immunotherapy Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the CAR-T Cellular Immunotherapy Drug revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global CAR-T Cellular Immunotherapy Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for CAR-T Cellular Immunotherapy Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, Kite Pharma, Bristol Myers Squibb and Fosun Pharma, etc.
By Company
- Novartis AG
- Kite Pharma
- Bristol Myers Squibb
- Fosun Pharma
- CD19-Targeted
- BCMA-Targeted
- Multiple Myeloma
- Non-Hodgkin lymphoma
- Leukemia
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of CAR-T Cellular Immunotherapy Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cellular Immunotherapy Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR-T Cellular Immunotherapy Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD19-Targeted
1.2.3 BCMA-Targeted
1.3 Market by Application
1.3.1 Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Multiple Myeloma
1.3.3 Non-Hodgkin lymphoma
1.3.4 Leukemia
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global CAR-T Cellular Immunotherapy Drug Market Perspective (2018-2029)
2.2 Global CAR-T Cellular Immunotherapy Drug Growth Trends by Region
2.2.1 CAR-T Cellular Immunotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR-T Cellular Immunotherapy Drug Historic Market Size by Region (2018-2023)
2.2.3 CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2024-2029)
2.3 CAR-T Cellular Immunotherapy Drug Market Dynamics
2.3.1 CAR-T Cellular Immunotherapy Drug Industry Trends
2.3.2 CAR-T Cellular Immunotherapy Drug Market Drivers
2.3.3 CAR-T Cellular Immunotherapy Drug Market Challenges
2.3.4 CAR-T Cellular Immunotherapy Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue CAR-T Cellular Immunotherapy Drug by Players
3.1.1 Global CAR-T Cellular Immunotherapy Drug Revenue by Players (2018-2023)
3.1.2 Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Players (2018-2023)
3.2 Global CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CAR-T Cellular Immunotherapy Drug, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio
3.4.1 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cellular Immunotherapy Drug Revenue in 2022
3.5 Global Key Players of CAR-T Cellular Immunotherapy Drug Head office and Area Served
3.6 Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application
3.7 Global Key Players of CAR-T Cellular Immunotherapy Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T CELLULAR IMMUNOTHERAPY DRUG BREAKDOWN DATA BY TYPE
4.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Type (2018-2023)
4.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2024-2029)
5 CAR-T CELLULAR IMMUNOTHERAPY DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Application (2018-2023)
5.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
6.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Type
6.2.1 North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
6.2.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
6.2.3 North America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
6.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Application
6.3.1 North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
6.3.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
6.3.3 North America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
6.4 North America CAR-T Cellular Immunotherapy Drug Market Size by Country
6.4.1 North America CAR-T Cellular Immunotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023)
6.4.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
7.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Type
7.2.1 Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
7.2.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
7.2.3 Europe CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
7.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Application
7.3.1 Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
7.3.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
7.3.3 Europe CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
7.4 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country
7.4.1 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023)
7.4.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
8.2 China CAR-T Cellular Immunotherapy Drug Market Size by Type
8.2.1 China CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
8.2.2 China CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
8.2.3 China CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
8.3 China CAR-T Cellular Immunotherapy Drug Market Size by Application
8.3.1 China CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
8.3.2 China CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
8.3.3 China CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
9.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Type
9.2.1 Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
9.2.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
9.2.3 Asia CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
9.3 Asia CAR-T Cellular Immunotherapy Drug Market Size by Application
9.3.1 Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
9.3.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
9.3.3 Asia CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
9.4 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region
9.4.1 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2023)
9.4.3 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Introduction
11.1.4 Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.1.5 Novartis AG Recent Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Introduction
11.2.4 Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.2.5 Kite Pharma Recent Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.3.5 Bristol Myers Squibb Recent Developments
11.4 Fosun Pharma
11.4.1 Fosun Pharma Company Details
11.4.2 Fosun Pharma Business Overview
11.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Introduction
11.4.4 Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.4.5 Fosun Pharma Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD19-Targeted
1.2.3 BCMA-Targeted
1.3 Market by Application
1.3.1 Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Multiple Myeloma
1.3.3 Non-Hodgkin lymphoma
1.3.4 Leukemia
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global CAR-T Cellular Immunotherapy Drug Market Perspective (2018-2029)
2.2 Global CAR-T Cellular Immunotherapy Drug Growth Trends by Region
2.2.1 CAR-T Cellular Immunotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR-T Cellular Immunotherapy Drug Historic Market Size by Region (2018-2023)
2.2.3 CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2024-2029)
2.3 CAR-T Cellular Immunotherapy Drug Market Dynamics
2.3.1 CAR-T Cellular Immunotherapy Drug Industry Trends
2.3.2 CAR-T Cellular Immunotherapy Drug Market Drivers
2.3.3 CAR-T Cellular Immunotherapy Drug Market Challenges
2.3.4 CAR-T Cellular Immunotherapy Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue CAR-T Cellular Immunotherapy Drug by Players
3.1.1 Global CAR-T Cellular Immunotherapy Drug Revenue by Players (2018-2023)
3.1.2 Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Players (2018-2023)
3.2 Global CAR-T Cellular Immunotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CAR-T Cellular Immunotherapy Drug, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio
3.4.1 Global CAR-T Cellular Immunotherapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cellular Immunotherapy Drug Revenue in 2022
3.5 Global Key Players of CAR-T Cellular Immunotherapy Drug Head office and Area Served
3.6 Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application
3.7 Global Key Players of CAR-T Cellular Immunotherapy Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T CELLULAR IMMUNOTHERAPY DRUG BREAKDOWN DATA BY TYPE
4.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Type (2018-2023)
4.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2024-2029)
5 CAR-T CELLULAR IMMUNOTHERAPY DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global CAR-T Cellular Immunotherapy Drug Historic Market Size by Application (2018-2023)
5.2 Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
6.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Type
6.2.1 North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
6.2.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
6.2.3 North America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
6.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Application
6.3.1 North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
6.3.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
6.3.3 North America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
6.4 North America CAR-T Cellular Immunotherapy Drug Market Size by Country
6.4.1 North America CAR-T Cellular Immunotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023)
6.4.3 North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
7.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Type
7.2.1 Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
7.2.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
7.2.3 Europe CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
7.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Application
7.3.1 Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
7.3.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
7.3.3 Europe CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
7.4 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country
7.4.1 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023)
7.4.3 Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
8.2 China CAR-T Cellular Immunotherapy Drug Market Size by Type
8.2.1 China CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
8.2.2 China CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
8.2.3 China CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
8.3 China CAR-T Cellular Immunotherapy Drug Market Size by Application
8.3.1 China CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
8.3.2 China CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
8.3.3 China CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
9.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Type
9.2.1 Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
9.2.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
9.2.3 Asia CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
9.3 Asia CAR-T Cellular Immunotherapy Drug Market Size by Application
9.3.1 Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
9.3.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
9.3.3 Asia CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
9.4 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region
9.4.1 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2023)
9.4.3 Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Introduction
11.1.4 Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.1.5 Novartis AG Recent Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Introduction
11.2.4 Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.2.5 Kite Pharma Recent Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.3.5 Bristol Myers Squibb Recent Developments
11.4 Fosun Pharma
11.4.1 Fosun Pharma Company Details
11.4.2 Fosun Pharma Business Overview
11.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Introduction
11.4.4 Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
11.4.5 Fosun Pharma Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-Targeted
Table 3. Key Players of BCMA-Targeted
Table 4. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2018-2023)
Table 8. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2024-2029)
Table 10. CAR-T Cellular Immunotherapy Drug Market Trends
Table 11. CAR-T Cellular Immunotherapy Drug Market Drivers
Table 12. CAR-T Cellular Immunotherapy Drug Market Challenges
Table 13. CAR-T Cellular Immunotherapy Drug Market Restraints
Table 14. Global CAR-T Cellular Immunotherapy Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Players (2018-2023)
Table 16. Global Top CAR-T Cellular Immunotherapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2022)
Table 17. Global CAR-T Cellular Immunotherapy Drug Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of CAR-T Cellular Immunotherapy Drug, Headquarters and Area Served
Table 20. Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application
Table 21. Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2018-2023)
Table 25. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2024-2029)
Table 27. Global CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Application (2018-2023)
Table 29. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Application (2024-2029)
Table 31. North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 46. China CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 48. China CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG CAR-T Cellular Immunotherapy Drug Product
Table 66. Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 67. Novartis AG Recent Developments
Table 68. Kite Pharma Company Details
Table 69. Kite Pharma Business Overview
Table 70. Kite Pharma CAR-T Cellular Immunotherapy Drug Product
Table 71. Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 72. Kite Pharma Recent Developments
Table 73. Bristol Myers Squibb Company Details
Table 74. Bristol Myers Squibb Business Overview
Table 75. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product
Table 76. Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 77. Bristol Myers Squibb Recent Developments
Table 78. Fosun Pharma Company Details
Table 79. Fosun Pharma Business Overview
Table 80. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product
Table 81. Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 82. Fosun Pharma Recent Developments
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 1. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-Targeted
Table 3. Key Players of BCMA-Targeted
Table 4. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2018-2023)
Table 8. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR-T Cellular Immunotherapy Drug Market Share by Region (2024-2029)
Table 10. CAR-T Cellular Immunotherapy Drug Market Trends
Table 11. CAR-T Cellular Immunotherapy Drug Market Drivers
Table 12. CAR-T Cellular Immunotherapy Drug Market Challenges
Table 13. CAR-T Cellular Immunotherapy Drug Market Restraints
Table 14. Global CAR-T Cellular Immunotherapy Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Players (2018-2023)
Table 16. Global Top CAR-T Cellular Immunotherapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2022)
Table 17. Global CAR-T Cellular Immunotherapy Drug Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of CAR-T Cellular Immunotherapy Drug, Headquarters and Area Served
Table 20. Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application
Table 21. Global Key Players of CAR-T Cellular Immunotherapy Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2018-2023)
Table 25. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR-T Cellular Immunotherapy Drug Revenue Market Share by Type (2024-2029)
Table 27. Global CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Application (2018-2023)
Table 29. Global CAR-T Cellular Immunotherapy Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR-T Cellular Immunotherapy Drug Revenue Share by Application (2024-2029)
Table 31. North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 46. China CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 48. China CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia CAR-T Cellular Immunotherapy Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG CAR-T Cellular Immunotherapy Drug Product
Table 66. Novartis AG Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 67. Novartis AG Recent Developments
Table 68. Kite Pharma Company Details
Table 69. Kite Pharma Business Overview
Table 70. Kite Pharma CAR-T Cellular Immunotherapy Drug Product
Table 71. Kite Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 72. Kite Pharma Recent Developments
Table 73. Bristol Myers Squibb Company Details
Table 74. Bristol Myers Squibb Business Overview
Table 75. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product
Table 76. Bristol Myers Squibb Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 77. Bristol Myers Squibb Recent Developments
Table 78. Fosun Pharma Company Details
Table 79. Fosun Pharma Business Overview
Table 80. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product
Table 81. Fosun Pharma Revenue in CAR-T Cellular Immunotherapy Drug Business (2018-2023) & (US$ Million)
Table 82. Fosun Pharma Recent Developments
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global CAR-T Cellular Immunotherapy Drug Market Share by Type: 2022 VS 2029
Figure 3. CD19-Targeted Features
Figure 4. BCMA-Targeted Features
Figure 5. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global CAR-T Cellular Immunotherapy Drug Market Share by Application: 2022 VS 2029
Figure 7. Multiple Myeloma Case Studies
Figure 8. Non-Hodgkin lymphoma Case Studies
Figure 9. Leukemia Case Studies
Figure 10. CAR-T Cellular Immunotherapy Drug Report Years Considered
Figure 11. Global CAR-T Cellular Immunotherapy Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global CAR-T Cellular Immunotherapy Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global CAR-T Cellular Immunotherapy Drug Market Share by Region: 2022 VS 2029
Figure 14. Global CAR-T Cellular Immunotherapy Drug Market Share by Players in 2022
Figure 15. Global Top CAR-T Cellular Immunotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2022
Figure 17. North America CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 19. North America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 20. North America CAR-T Cellular Immunotherapy Drug Market Share by Country (2018-2029)
Figure 21. United States CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 25. Europe CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 26. Europe CAR-T Cellular Immunotherapy Drug Market Share by Country (2018-2029)
Figure 27. Germany CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 35. China CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 36. Asia CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 38. Asia CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 39. Asia CAR-T Cellular Immunotherapy Drug Market Share by Region (2018-2029)
Figure 40. Japan CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Country (2018-2029)
Figure 50. Brazil CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Novartis AG Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 57. Kite Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 59. Fosun Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Figure 1. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global CAR-T Cellular Immunotherapy Drug Market Share by Type: 2022 VS 2029
Figure 3. CD19-Targeted Features
Figure 4. BCMA-Targeted Features
Figure 5. Global CAR-T Cellular Immunotherapy Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global CAR-T Cellular Immunotherapy Drug Market Share by Application: 2022 VS 2029
Figure 7. Multiple Myeloma Case Studies
Figure 8. Non-Hodgkin lymphoma Case Studies
Figure 9. Leukemia Case Studies
Figure 10. CAR-T Cellular Immunotherapy Drug Report Years Considered
Figure 11. Global CAR-T Cellular Immunotherapy Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global CAR-T Cellular Immunotherapy Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global CAR-T Cellular Immunotherapy Drug Market Share by Region: 2022 VS 2029
Figure 14. Global CAR-T Cellular Immunotherapy Drug Market Share by Players in 2022
Figure 15. Global Top CAR-T Cellular Immunotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cellular Immunotherapy Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by CAR-T Cellular Immunotherapy Drug Revenue in 2022
Figure 17. North America CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 19. North America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 20. North America CAR-T Cellular Immunotherapy Drug Market Share by Country (2018-2029)
Figure 21. United States CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 25. Europe CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 26. Europe CAR-T Cellular Immunotherapy Drug Market Share by Country (2018-2029)
Figure 27. Germany CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 35. China CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 36. Asia CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 38. Asia CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 39. Asia CAR-T Cellular Immunotherapy Drug Market Share by Region (2018-2029)
Figure 40. Japan CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America CAR-T Cellular Immunotherapy Drug Market Share by Country (2018-2029)
Figure 50. Brazil CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries CAR-T Cellular Immunotherapy Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Novartis AG Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 57. Kite Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 59. Fosun Pharma Revenue Growth Rate in CAR-T Cellular Immunotherapy Drug Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
